super responder semaglutide Super-Responders” to Liraglutide Monotherapy and the Growing Evidence of Efficacy of GLP-1 Analogues in Obesity Management: A Longitudinal Prospective Cohort Study Phenomix Test Identifies Ozempic and

However, exercise does potentiate many of the outcomes you are taking semaglutide to achieve

Ozempic, Mounjaro, and Rybelsus are approved for type 2 diabetes, so prescribing them for weight loss is an off-label use

While the Bridge is an important milestone, it should also be a catalyst for creating a permanent pathway to comprehensive obesity care within Medicare and across private insurance as well." Novo Nordisk is actively working with CMS, healthcare professionals, pharmacists, and patient advocacy organizations to support implementation and help ensure patients can access the medicines they need

Always consult with a licensed healthcare provider before starting or stopping any medication or supplement